Table 2 Quantitative real-time PCR analysis for the mRNA expressions in sham-operated (SO) and bile-duct-ligated (BDL) rats receiving armepavine (Arm), silymarin (sil) or vehicle (0.7% CMC) treatment

col1α2/GAPDH

1.00 ± 0.44

12.5 ± 0.2*

7.31 ± 0.11*^,#

7.45 ± 0.08*^,#

5.09 ± 0.23*^,#

TGF-β1/GAPDH

1.00 ± 0.81

21.5 ± 0.2*

13.1 ± 0.9*^,#

14.5 ± 0.8*^,#

7.09 ± 1.72*^,#

TIMP-1/GAPDH

1.01 ± 0.84

28.0 ± 2.6*

4.93 ± 1.88*^,#

4.36 ± 1.70*^,#

3.87 ± 1.59*^,#

ICAM-1/GAPDH

1.00 ± 0.20

22.5 ± 0.5*

12.2 ± 0.1*^,#

15.5 ± 0.2*^,#

7.03 ± 0.35*^,#

iNOS/GAPDH

1.00 ± 0.08

7.53 ± 0.17*

5.31 ± 0.09*^,#

6.45 ± 0.08*^,#

3.09 ± 0.31*^,#

IL-6/GAPDH

1.00 ± 0.10

31.5 ± 0.3*

11.3 ± 0.1*^,#

10.5 ± 0.1*^,#

4.09 ± 0.17*^,#

Metallothionein/GAPDH

1.00 ± 0.10

0.34 ± 0.06*

0.56 ± 0.08*^,#

0.37 ± 0.10*

0.57 ± 0.05*^,#